From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

President Trump's complaint is that foreigners and big pharmaceutical companies have conspired to steal America's pharma jobs, shipping factories overseas to places like Ireland. A few weeks ago he ...

Improving relationships between pharmaceutical makers, health systems, patients, and insurers can help to lower the price of ...

Q3 2025 Earnings Call Transcript May 1, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.35, ...

Should the bill pass, it will introduce “federal tax benefits and other incentives” to American-based companies seeking to ...

Over the last month, it’s become increasingly clear how Trump’s tariffs are already wreaking havoc across virtually every ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

As multiple large drugmakers look to navigate trade turbulence by pumping billions of dollars into their U.S. | Eli Lilly CEO Dave Ricks is joining a growing number of pharma chiefs calling for tax ...

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...

Announcing first-quarter results, Biogen CEO Chris Viehbacher admitted that tariffs are “a new topic for us,” but said he ...